Compare AMRX & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | IRTC |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.9B |
| IPO Year | 2018 | 2016 |
| Metric | AMRX | IRTC |
|---|---|---|
| Price | $16.21 | $104.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $15.60 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 1.8M | 472.6K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 61.71 |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | ★ $747,138,000.00 |
| Revenue This Year | $4.48 | $19.60 |
| Revenue Next Year | $7.13 | $15.94 |
| P/E Ratio | $84.29 | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $7.67 | $100.85 |
| 52 Week High | $16.61 | $210.01 |
| Indicator | AMRX | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 78.56 | 39.87 |
| Support Level | $12.46 | $101.75 |
| Resistance Level | N/A | $121.88 |
| Average True Range (ATR) | 0.57 | 5.32 |
| MACD | 0.27 | -0.31 |
| Stochastic Oscillator | 90.29 | 22.07 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.